Industry Valuation and Performance
Has the U.S. Life Sciences Industry valuation changed over the past few years?
Date Market Cap Revenue Earnings PE Absolute PE PS Wed, 30 Nov 2022 US$747.9b US$155.1b US$8.8b 28.1x 85.2x 4.8x Fri, 28 Oct 2022 US$714.1b US$154.5b US$17.0b 26.6x 41.9x 4.6x Sun, 25 Sep 2022 US$713.9b US$152.2b US$17.3b 25.5x 41.3x 4.7x Tue, 23 Aug 2022 US$800.2b US$152.2b US$17.3b 30.6x 46.2x 5.3x Thu, 21 Jul 2022 US$754.8b US$148.1b US$20.1b 31x 37.6x 5.1x Sat, 18 Jun 2022 US$678.3b US$148.1b US$20.1b 27.5x 33.7x 4.6x Mon, 16 May 2022 US$726.4b US$148.0b US$20.0b 30.4x 36.2x 4.9x Wed, 13 Apr 2022 US$845.2b US$146.5b US$25.3b 36x 33.4x 5.8x Fri, 11 Mar 2022 US$819.3b US$146.2b US$25.3b 35.3x 32.4x 5.6x Sun, 06 Feb 2022 US$862.7b US$139.8b US$26.9b 40.3x 32.1x 6.2x Tue, 04 Jan 2022 US$969.3b US$138.0b US$27.3b 44.1x 35.5x 7x Thu, 02 Dec 2021 US$960.6b US$138.0b US$27.3b 44.3x 35.2x 7x Sat, 30 Oct 2021 US$754.1b US$107.8b US$21.5b 48.3x 35.1x 7x Mon, 27 Sep 2021 US$766.7b US$105.9b US$18.6b 53.1x 41.1x 7.2x Wed, 25 Aug 2021 US$730.3b US$105.8b US$18.7b 51.9x 39.1x 6.9x Thu, 01 Jul 2021 US$656.3b US$101.0b US$17.6b 39.3x 37.2x 6.5x Sun, 04 Apr 2021 US$569.5b US$92.3b US$15.4b 38.8x 37x 6.2x Wed, 06 Jan 2021 US$553.9b US$89.0b US$14.2b 39x 39x 6.2x Sat, 10 Oct 2020 US$450.0b US$79.8b US$11.8b 38.6x 38.2x 5.6x Fri, 03 Jul 2020 US$388.7b US$77.1b US$8.8b 38.4x 44x 5x Mon, 06 Apr 2020 US$302.9b US$77.3b US$8.5b 30.2x 35.5x 3.9x Thu, 09 Jan 2020 US$360.7b US$76.7b US$8.9b 35.2x 40.4x 4.7x 1Y 3Y 5Y 10Y Price to Earnings Price to Sales Median Price to Earnings Price to Earnings Ratio
Sat, 07 Dec 2019 Total Market Cap: US$346.8b Total Earnings: US$7.0b Total Revenue: US$75.6b Total Market Cap vs Earnings and Revenue 0% 0% 0% U.S. Life Sciences Industry Price to Earnings 3Y Average 40.3x 2020 2021 2022 Current Industry PE Investors are optimistic on the American Life Sciences industry, and appear confident in long term growth rates. The industry is trading at a PE ratio of 85.2x which is higher than its 3-year average PE of 40.3x. The 3-year average PS ratio of 5.7x is higher than the industry's current PS ratio of 4.8x. Past Earnings Growth The earnings for companies in the Life Sciences industry have grown 7.7% per year over the last three years. Revenues for these companies have grown 27% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too. Industry Trends
Which industries have driven the changes within the U.S. Healthcare industry?
7D 1M 3M 1Y 3Y 5Y US Market -0.94% Healthcare -0.045% Life Sciences -1.67% Clinical Research and Equipment -1.67% Industry PEThere are no additional sub-industries under this industry. Forecasted GrowthThere are no additional sub-industries under this industry. Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
Simply Wall St ™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.